Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ERK inhibitor, ulixertinib induces transcriptomic changes in NGP cells

ABSTRACT: ERK inhibitor, ulixertinib induces transcriptomic changes in NGP cells

PROVIDER: PRJNA879348 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21530273_1.fastq.gz	Fastqsanger.gz
	SRR21530273_2.fastq.gz	Fastqsanger.gz
	SRR21530274_1.fastq.gz	Fastqsanger.gz
	SRR21530274_2.fastq.gz	Fastqsanger.gz
	SRR21530275_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

ERK inhibitor, ulixertinib induces transcriptomic changes in NGP cells

Project description:To investigate the effect of ERK inhibitor, ulixertinib, on NB cell proliferation and delineate the mechanisms of ulixertinib-mediated ERK pathway inhibition in NB. We treated human neuroblastoma cell line, NGP with ulixertinib and performed gene expression profiling analysis using data obtained from RNA-seq.

2023-03-01 | GSE213153 | GEO

CAMKV inhibitor, OTSSP167 induces transcriptomic changes in NGP cells

Project description:CAMKV inhibitor, OTSSP167 induces transcriptomic changes in NGP cells

| PRJNA1076169 | ENA

CAMKV inhibitor, OTSSP167 induces transcriptomic changes in NGP cells

Project description:To investigate the effect of CAMKV inhibitor, OTSSP167, on NB cell proliferation and delineate the mechanisms of CAMKV-mediated pathway inhibition in NB. We treated human neuroblastoma cell line, NGP with OTSSP167 and performed gene expression profiling analysis using data obtained from RNA-seq.

2024-10-24 | GSE255692 | GEO

CAMKV geneknockown induces transcriptomic changes in neuroblastoma cell line NGP

Project description:CAMKV geneknockown induces transcriptomic changes in neuroblastoma cell line NGP

| PRJNA1076170 | ENA

CAMKV geneknockown induces transcriptomic changes in neuroblastoma cell line NGP

Project description:To investigate the effect of CAMKV knockdown on transcriptomic profiling in neuroblastoma and delineate the role of CAMJV in neuroblastoma growth. We knockdowned the gene exprssion of CAMKV in NGP cells and performed gene expression profiling analysis using data obtained from RNA-seq.

2024-10-24 | GSE255691 | GEO

Global gene expression analysis in NGP CRISPR control cells and NGP ALK(LF655del) cells.

Project description:We performed gene expression profiling by Affymetrix primeview array in both NGP CRISPR control cells and NGP ALK(LF655del) cells.

2021-08-11 | GSE140025 | GEO

ERK inhibitor treatment in Pa16C pancreatic cancer cells

Project description:Pa16C cells treated every other day with the ERK inhibitor SCH772984 and assayed at 3 or 7 days post-treatment

2020-06-29 | GSE119548 | GEO

ERK inhibitor treatment in Pa16C pancreatic cancer cells

Project description:ERK inhibitor treatment in Pa16C pancreatic cancer cells

| PRJNA489493 | ENA

SMARTer single cell total RNA sequencing [NGP]

Project description:single cell polyA+ and total RNA-seq data was generated for NGP, SK-N-BE-2C and SHSY5Y-MYCN-TR cells

2019-01-01 | GSE119936 | GEO

Transcriptional Profiling Defines the Roles of ERK and p38 Kinases in Epidermal Keratinocytes

Project description:Epidermal keratinocytes respond to extracellular influences by activating cytoplasmic signal transduction pathways that change the transcriptional profiles of affected cells. To define responses to two such pathways, p38 and ERK, we used SB203580 and PD98059 as specific inhibitors, and identified the regulated genes after 1, 4, 24 and 48 hrs, using Affymetrix’ Hu133Av2 microarrays. Additionally, we compared genes specifically regulated by p38 and ERKs with those regulated by JNK and by all three pathways simultaneously. We find that the p38 pathway induces the expression of extracellular matrix and proliferation-associated genes, while suppressing microtubule-associated genes; the ERK pathway induces the expression of nuclear envelope and mRNA splicing proteins, while suppressing steroid synthesis and mitochondrial energy production enzymes. Both pathways promote epidermal differentiation and induce feedback inactivation of MAPK signaling. c-FOS, SRY and N-Myc appear to be the principal targets of the p38 pathway, Elk-1 SAP1 and HLH2 of ERK, while FREAC-4, ARNT and USF are common to both. The results for the first time comprehensively define the genes regulated by the p38 and ERK pathways in epidermal keratinocytes and suggest a list of targets potentially useful in therapeutic interventions. Human epidermal keratinocytes are grown in Keratinocyte Serum-Free Medium (Gibco) supplemented with 0.05 mg/ml bovine pituitary extract, 2.5 ng/ml epidermal growth factor, 0.09 mM CalCl2 and 1% penicillin/streptomycin (KGM). They are switched to Keratinocyte Serum Free-Media (Gibco) supplemented only with 1% penicillin/streptomycin (KBM) 24 h prior to commencing experiments. A set is left as controls, others treated with 5 uM JNK inhibitor SP600125, 15 uM p38 inhibitor SB203580, or 50 um ERK inhibitor PD98059. Timecourse of treated and parellel control samples over a 48 hr period was performed.

2013-09-05 | E-GEOD-50591 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data